| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma
|
Zurita, A.J.
|
|
|
23 |
1 |
p. 46-52
|
artikel
|
| 2 |
A meta-analysis on alcohol drinking and gastric cancer risk
|
Tramacere, I.
|
|
|
23 |
1 |
p. 28-36
|
artikel
|
| 3 |
A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer
|
Manegold, C.
|
|
|
23 |
1 |
p. 72-77
|
artikel
|
| 4 |
A phase I study of sunitinib in combination with FOLFIRI in patients with untreated metastatic colorectal cancer
|
Starling, N.
|
|
|
23 |
1 |
p. 119-127
|
artikel
|
| 5 |
A phase 2 study of patupilone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: Canadian Urologic Oncology Group study P07a
|
Chi, K.N.
|
|
|
23 |
1 |
p. 53-58
|
artikel
|
| 6 |
Association between dietary folate intake and clinical outcome in head and neck squamous cell carcinoma
|
Kawakita, D.
|
|
|
23 |
1 |
p. 186-192
|
artikel
|
| 7 |
Autologous stem-cell transplantation in patients with mantle cell lymphoma beyond 65 years of age: a study from the European Group for Blood and Marrow Transplantation (EBMT)
|
Jantunen, E.
|
|
|
23 |
1 |
p. 166-171
|
artikel
|
| 8 |
Bevacizumab-induced laryngeal necrosis
|
Hartl, D.M.
|
|
|
23 |
1 |
p. 276-278
|
artikel
|
| 9 |
Chemoradiotherapy for anal cancer in HIV patients causes prolonged CD4 cell count suppression
|
Alfa-Wali, M.
|
|
|
23 |
1 |
p. 141-147
|
artikel
|
| 10 |
Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG)
|
Garbay, D.
|
|
|
23 |
1 |
p. 182-186
|
artikel
|
| 11 |
Clinically relevant fatigue in recurrence-free prostate cancer survivors
|
Storey, D.J.
|
|
|
23 |
1 |
p. 65-72
|
artikel
|
| 12 |
Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials
|
Reiman, T.
|
|
|
23 |
1 |
p. 86-93
|
artikel
|
| 13 |
Dairy products and colorectal cancer risk: a systematic review and meta-analysis of cohort studies
|
Aune, D.
|
|
|
23 |
1 |
p. 37-45
|
artikel
|
| 14 |
Diabetes and non-Hodgkin’s lymphoma: analyses of prevalence and annual incidence in 2005 using the National Health Insurance database in Taiwan
|
Tseng, C.-H.
|
|
|
23 |
1 |
p. 153-158
|
artikel
|
| 15 |
Dissecting responsive phenotypes through cytokine and angiogenic factor analysis
|
Rini, B.
|
|
|
23 |
1 |
p. 6-7
|
artikel
|
| 16 |
Diverging trends in incidence and mortality, and improved survival of non-Hodgkin's lymphoma, in the Netherlands, 1989–2007
|
van de Schans, S.A.M.
|
|
|
23 |
1 |
p. 171-182
|
artikel
|
| 17 |
Do patients with invasive lobular breast cancer benefit in terms of adequate change in surgical therapy from a supplementary preoperative breast MRI?
|
Heil, J.
|
|
|
23 |
1 |
p. 98-104
|
artikel
|
| 18 |
Editorial board
|
|
|
|
23 |
1 |
p. ii-iii
|
artikel
|
| 19 |
Effect of protocol-related variables and women's characteristics on the cumulative false-positive risk in breast cancer screening
|
Román, R.
|
|
|
23 |
1 |
p. 104-111
|
artikel
|
| 20 |
Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial
|
Durand, J.P.
|
|
|
23 |
1 |
p. 200-205
|
artikel
|
| 21 |
Expert second-opinion pathology review of lymphoma in the era of the World Health Organization classification
|
Matasar, M.J.
|
|
|
23 |
1 |
p. 159-166
|
artikel
|
| 22 |
Fiber intake and pancreatic cancer risk: a case–control study
|
Bidoli, E.
|
|
|
23 |
1 |
p. 264-268
|
artikel
|
| 23 |
First-line bevacizumab-containing therapy for breast cancer: results in patients aged ≥70 years treated in the ATHENA study
|
Biganzoli, L.
|
|
|
23 |
1 |
p. 111-118
|
artikel
|
| 24 |
2-18fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial
|
Bachner, M.
|
|
|
23 |
1 |
p. 59-64
|
artikel
|
| 25 |
Impact of a novel nurse-led prechemotherapy education intervention (ChemoEd) on patient distress, symptom burden, and treatment-related information and support needs: results from a randomised, controlled trial
|
Aranda, S.
|
|
|
23 |
1 |
p. 222-231
|
artikel
|
| 26 |
Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience
|
Vandone, A.M.
|
|
|
23 |
1 |
p. 193-200
|
artikel
|
| 27 |
Integrative oncology in the Middle East: from traditional herbal knowledge to contemporary cancer care
|
Ben-Arye, E.
|
|
|
23 |
1 |
p. 211-221
|
artikel
|
| 28 |
Investigating changes over time in socioeconomic gaps in cancer survival: using differences in relative survival versus differences in excess mortality rates can give different answers
|
Blakely, T.
|
|
|
23 |
1 |
p. 278-279
|
artikel
|
| 29 |
New treatment modalities in advanced thyroid cancer
|
Kapiteijn, E.
|
|
|
23 |
1 |
p. 10-18
|
artikel
|
| 30 |
Novel measurements of mammary stem cells in human umbilical cord blood as prospective predictors of breast cancer susceptibility in later life
|
Qiu, L.
|
|
|
23 |
1 |
p. 245-250
|
artikel
|
| 31 |
Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries
|
Corbo, V.
|
|
|
23 |
1 |
p. 127-134
|
artikel
|
| 32 |
Phase Ib trial of radiotherapy in combination with combretastatin-A4-phosphate in patients with non-small-cell lung cancer, prostate adenocarcinoma, and squamous cell carcinoma of the head and neck
|
Ng, Q.-S.
|
|
|
23 |
1 |
p. 231-237
|
artikel
|
| 33 |
Physician, patient and family attitudes regarding information on prognosis: a Brazilian survey
|
Fumis, R.R.L.
|
|
|
23 |
1 |
p. 205-211
|
artikel
|
| 34 |
Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer
|
Catalano, V.
|
|
|
23 |
1 |
p. 135-141
|
artikel
|
| 35 |
Prostate cancer treatment ascertained from several sources: analysis of disagreement and error
|
Goodman, M.
|
|
|
23 |
1 |
p. 256-263
|
artikel
|
| 36 |
R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. A population-based investigation from the Danish Lymphoma Group
|
Gang, A.O.
|
|
|
23 |
1 |
p. 147-153
|
artikel
|
| 37 |
Reply to investigating changes over time in socioeconomic gaps in cancer survival: does choice of approach matter?
|
Lyratzopoulos, G.
|
|
|
23 |
1 |
p. 279-280
|
artikel
|
| 38 |
Responses to subsequent anti-HER2 therapy after treatment with trastuzumab-DM1 in women with HER2-positive metastatic breast cancer
|
Olson, E.M.
|
|
|
23 |
1 |
p. 93-97
|
artikel
|
| 39 |
Risk for incident and fatal prostate cancer in men with a family history of any incident and fatal cancer
|
Brandt, A.
|
|
|
23 |
1 |
p. 251-256
|
artikel
|
| 40 |
Sexual (dys)function and the quality of sexual life in patients with colorectal cancer: a systematic review
|
Traa, M.J.
|
|
|
23 |
1 |
p. 19-27
|
artikel
|
| 41 |
Sorafenib-induced diarrhea and hypophosphatemia: mechanisms and therapeutic implications
|
Mir, O.
|
|
|
23 |
1 |
p. 280-281
|
artikel
|
| 42 |
Subsequent cancers in patients diagnosed with cancer of unknown primary (CUP): etiological insights?
|
Shu, X.
|
|
|
23 |
1 |
p. 269-275
|
artikel
|
| 43 |
Table of Contents
|
|
|
|
23 |
1 |
p. iv-vi
|
artikel
|
| 44 |
Temsirolimus in combination with carboplatin and paclitaxel in patients with advanced solid tumors: a NCIC-CTG, phase I, open-label dose-escalation study (IND 179)
|
Kollmannsberger, C.
|
|
|
23 |
1 |
p. 238-244
|
artikel
|
| 45 |
Thanks to referees 2011
|
|
|
|
23 |
1 |
p. 1-5
|
artikel
|
| 46 |
The ARCAD advanced colorectal cancer database—open for business
|
Buyse, M.
|
|
|
23 |
1 |
p. 281-282
|
artikel
|
| 47 |
The hazards of randomized phase II trials
|
Lara, P.N.
|
|
|
23 |
1 |
p. 7-9
|
artikel
|
| 48 |
The impact of phosphorylated AMP-activated protein kinase expression on lung cancer survival
|
William, W.N.
|
|
|
23 |
1 |
p. 78-85
|
artikel
|
Tijdschrift beschrijving